Although Pathviewv.1.40.0 and Gagev2.50.0-determined CHUK and NFKB1 were downregulated in multiple pathways, DESeq2v1.40.2 analysis determined their expression to be 0.72 and 0.88 log2FC higher in OSCC samples than BC samples, respectively. Here, CHUK is linked to breast cancer.